Kara Okahara
Family Medicine · Hilo, HINPI 1417091893
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 380 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,889 and has fallen 59.9% since, to $758 in 2025. Among family medicine clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 380 payments — averaging $22.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$2K
- Amgen$2K
- AstraZeneca$650
- Novo Nordisk$497
- Pfizer$470
- AbbVie$415
- plus $3K from 23 others
What the payments were for
- Food & beverage$8,723100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 64 | $1,744 |
| Amgen | 67 | $1,519 |
| AstraZeneca | 18 | $650 |
| Novo Nordisk | 28 | $497 |
| Pfizer | 22 | $470 |
| AbbVie | 18 | $415 |
| Lilly USA, LLC | 23 | $411 |
| Lundbeck LLC | 18 | $359 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $328 |
| Amarin Pharma, Inc. | 13 | $323 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $268 |
| Sanofi-aventis U.S. LLC | 12 | $238 |
| Merck | 8 | $218 |
| Kowa Pharmaceuticals America, Inc. | 9 | $209 |
| Otsuka America Pharmaceutical, Inc. | 9 | $206 |
| GSK | 7 | $141 |
| Bayer | 5 | $117 |
| Esperion Therapeutics, Inc. | 5 | $110 |
| Eisai Inc. | 5 | $99 |
| Axsome Therapeutics, Inc. | 2 | $60 |
| Johnson & Johnson | 3 | $56 |
| Radius Health, Inc. | 2 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $50 |
| Novartis | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $37 |
| Sanofi | 1 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Exact Sciences | 1 | $25 |
| Ironwood Pharmaceuticals, Inc | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,723 in reported general payments places this provider in the 90th percentile of 376 family medicine providers in Hawaii.
Other family medicine in Hilo
- Buddy FesterlingHilo$20K
- Roy KogaHilo$20K
- Douglas OlsenHilo$13K
- Charles SonidoHilo$8K
- Matthew DykemaHilo$8K
- Richard Lee-ChingHilo$3K
- Gina Marie SalcedoHilo$3K
- Brian StolleyKihei$126K
- Vicente RamoHonolulu$34K
- Edward AlqueroWaipahu$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.